𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PPFIA1 and CCND1 are frequently coamplified in breast cancer

✍ Scribed by Ana-Maria Dancau; Laura Wuth; Marcel Waschow; Frederik Holst; Antje Krohn; Matthias Choschzick; Luigi Terracciano; Sotirios Politis; Stefan Kurtz; Annette Lebeau; Kay Friedrichs; Katharina Wencke; Outi Monni; Ronald Simon

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
218 KB
Volume
49
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Recently, amplification of PPFIA1, encoding a member of the liprin family located about 600 kb telomeric to CCND1 on chromosome band 11q13, was described in squamous cell carcinoma of head and neck. Because 11q13 amplification is frequent in breast cancer, and PPFIA1 has been suggested to contribute to mammary gland development, we hypothesized that PPFIA1 might also be involved in the 11q13 amplicon in breast cancer and contribute to breast cancer development. A tissue microarray containing more than 2000 human breast cancers was analyzed for gene copy numbers of PPFIA1 and CCND1 by means of fluorescence in situ hybridization. PPFIA1 amplification was found in 248/1583 (15.4%) of breast cancers. Coamplification with CCND1 was found in all (248/248, 100%) PPFIA1‐amplified cancers. CCND1 amplification without PPFIA1 coamplification was found in additional 117 (4.7%) tumors. Amplification of both PPFIA1 and CCND1 were significantly associated with high‐grade phenotype (P = 0.0002) but were unrelated to tumor stage (P = 0.7066) or nodal stage (P = 0.5807). No difference in patient prognosis was found between 248 CCND1/PPFIA1 coamplified tumors and 117 tumors with CCND1 amplification alone (P = 0.6419). These data show that PPFIA1 amplification occurs frequently in breast cancer. The higher incidence of CCND1 amplification when compared with PPFIA1, the lack of prognostic relevance of coamplifications, and the fact that PPFIA1 amplification was found exclusively in CCND1‐amplified cancers suggest that PPFIA1 gene copy number changes represent concurrent events of CCND1 amplification rather than specific biological incidents. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Frequent amplification and overexpressio
Frequent amplification and overexpression of CCND1 in male breast cancer
✍ Maarit Bärlund; Tuula Kuukasjärvi; Kirsi Syrjäkoski; Anssi Auvinen; Anne Kallion 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract Genetic events underlying the pathogenesis of breast cancer have been studied extensively and several clinically significant markers have been identified. For example, amplification and overexpression of the __ERBB2__ oncogene is associated with poor prognosis in breast cancer and __ERB

Polymorphic loci of E2F2, CCND1 and CCND
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors
✍ Christina Justenhoven; Christiane B. Pierl; Susanne Haas; Hans-Peter Fischer; Ut 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB

## Abstract Overexpression of the human epidermal growth factor receptor 2 (HER2) in breast tumors is associated with bad prognosis. Therefore, it is highly relevant to further improve understanding of the regulatory mechanisms of HER2 expression. In addition to gene amplification, transcriptional

MYEOV: A candidate gene for DNA amplific
MYEOV: A candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer
✍ Johannes W.G. Janssen; Marguerite Cuny; Béatrice Orsetti; Carmen Rodriguez; Hélè 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 322 KB

## Abstract Rearrangements of chromosome 11q13 are frequently observed in human cancer. The 11q13 region harbors several chromosomal breakpoint clusters found in hematologic malignancies and exhibits frequent DNA amplification in carcinomas. DNA amplification patterns in breast tumors are consisten

The DDX1 gene maps within 400 kbp 5′ to
The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma
✍ Lukas C. Amler; Jörg Schürmann; Manfred Schwab 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Human neuroblastoma cells frequently show amplification of the oncogene MYCN, which maps to 2p24. Previous studies have localized the DEAD box motif gene DDXl to the same chromosome band and demonstrated coamplification of DDXl and MYCN in two retinoblastoma cell lines. Recently, a high frequency of

CCND1 rs9344 polymorphisms are associate
CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population
✍ Ning Wang; Xiuyan Qian; Shizhuo Wang; Hong Gao; Lili Wang; Yunlong Huo; Shulan Z 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

## Abstract Cyclin D1, with a common G/A polymorphism in rs9344, is an essential regulator of the G1 phase in cell cycles and plays an important role in several tumor types, and the homology of cyclin D1 with human papillomavirus (HPV)‐16 E7 brought our attention to __CCND1__ gene in cervical cance

Antibodies against the cancer-testis ant
Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence
✍ Raphael B. Parmigiani; Fabiana Bettoni; Daniela M Grosso; Ademar Lopes; Isabela 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 221 KB

## Abstract Cancer‐testis (CT) antigens are immunogenic proteins expressed in normal gametogenic tissues and in different types of tumors. CTSP‐1 is a CT antigen frequently expressed in prostate tumors, and capable of eliciting humoral response in prostate cancer patients. Here, we analyzed the pre